The biotech company has proposed a new hybrid approach based on artificial intelligence and molecular modeling that significantly speeds up and simplifies the lengthy and complicated process of drug design.

Thanks to the financial support received within the framework of the “Neruzh” governmental program, “Biocentric” has expanded its team, acquired a material and certain technical base and now successfully continues its activities in the sphere of biotechnology.

The founders of "Biocentric" will take part in the event of the "Neruzh 4.0" program to be held in Dilijan on August 23-28, sharing their experience with the participants.